# FTO — Fat mass and obesity-associated protein
URL: https://genohealth.app/genes/fto
Category: Metabolic & weight
Chromosome: 16q12.2
Key variants: rs9939609
Last reviewed: 2026-04-25

## Summary
FTO is the most-studied obesity-related gene. The risk allele at rs9939609 increases appetite, snacking behavior and body fat — but its effect is largely offset by aerobic exercise and high-protein meals.

## What it does
FTO encodes an RNA demethylase that influences hypothalamic appetite signaling, ghrelin response and adipocyte differentiation. Risk-allele (A) carriers tend to feel hungrier sooner after meals, prefer energy-dense foods, and consume ~125-280 more kcal/day on average.

## Why it matters
Each risk allele adds ~1.5 kg of body weight on average — but consistent aerobic exercise (≥150 min/week) reduces this effect by ~30%, and high-protein meals (>30g protein) blunt the appetite signal. FTO is the canonical example of a "genetics loads the gun, environment pulls the trigger" gene.

## Variants
- rs9939609 — risk allele A; Each A allele increases BMI ~0.4 kg/m² and appetite/snacking. (frequency: A allele ≈42% in Europeans, 52% in West Africans.)
- rs1421085 — risk allele n/a; In strong linkage with rs9939609; some evidence rs1421085 is the causal SNP via IRX3/IRX5. (frequency: ≈42%)

## Genotypes
- **TT** (~36% of Europeans): Lower obesity risk; normal appetite signaling. → Standard healthy-eating guidance applies.
- **AT** (~48%): Moderate risk; ~1.5 kg average weight increase. → Anchor meals with 30g+ protein, prioritize fiber, stay active.
- **AA** (~16%): Highest risk; ~3 kg average increase; greater hunger between meals. → 30-40g protein per meal, 150-300 min/wk aerobic exercise, resistance training 2-3x/week, strict liquid-calorie limit.

## Conditions
- **Obesity** — Increased risk: Modest per-allele effect (~1.5 kg) but population-level impact is large.
- **Type 2 diabetes** — Increased risk (mediated by adiposity): Effect largely disappears after adjusting for BMI.
- **Cardiovascular disease** — Increased risk (mediated by adiposity): Same — manage weight to manage risk.

## Diet
Rationale: High-protein meals blunt ghrelin and improve satiety more in FTO risk-allele carriers than non-carriers. Fiber slows gastric emptying. Liquid calories deliver energy without triggering satiety — the worst possible match for FTO AA.
Prioritize: Lean protein at every meal (chicken, fish, eggs, Greek yogurt, tofu, lentils); High-fiber vegetables (broccoli, cauliflower, leafy greens); Berries and whole fruit; Legumes and beans; Water (replace sweetened drinks)
Limit: Sugar-sweetened beverages and juice (bypass FTO satiety signaling); Ultra-processed snacks engineered for hyperpalatability; Large portions of refined carbs without protein

## Lifestyle
- 150-300 minutes/week of moderate aerobic exercise (walking, cycling, swimming).
- Resistance training 2-3x/week to preserve muscle and metabolic rate.
- 7-9 hours of sleep — sleep deprivation amplifies FTO-driven appetite.
- Plate method: half vegetables, quarter protein, quarter starch.
- Eat slowly; allow 20 min for satiety signaling.

## Supplements
- **Whey or plant protein powder** — 20-30g once or twice daily, form: Whey isolate, pea/rice blend, or hemp. Easy way to hit protein targets; pre-meal whey reduces subsequent intake in AA carriers.
- **Soluble fiber (psyllium, glucomannan)** — 5-10g before main meals, form: Psyllium husk powder. Improves satiety; take with plenty of water.
- **Berberine** — 500 mg 2-3x/day with meals, form: Berberine HCl. Modestly improves insulin sensitivity and appetite; discuss with clinician — interacts with several medications.
- **Chromium picolinate** — 200-400 mcg/day, form: Picolinate or polynicotinate. Modest effect on glucose-driven cravings.

## Contraindications
- GLP-1 medications (semaglutide, tirzepatide) work well in FTO carriers but should be prescribed by a clinician — not self-sourced.
- Avoid extreme low-carb diets long-term without monitoring; sustainable patterns (Mediterranean, high-protein) outperform.

## FAQ
**Q: Am I destined to gain weight if I have FTO risk alleles?**
A: No. The genetic effect is modest (~1.5 kg per allele) and largely offset by exercise and high-protein meals. Behavior dominates outcome.

**Q: What is the best diet for FTO AA?**
A: High-protein (30-40g per meal), high-fiber, Mediterranean-style. Strictly limit sugar-sweetened beverages, which bypass FTO satiety signaling. Whole foods over ultra-processed.

**Q: Does FTO affect weight loss?**
A: Risk-allele carriers lose weight at the same rate as non-carriers when intervention is adequate. The challenge is adherence — appetite is harder to manage. Structured exercise and protein-anchored meals close the gap.

**Q: Should FTO carriers try GLP-1 medications?**
A: Eligibility is based on BMI and comorbidities, not genotype. That said, GLP-1 agonists target the same hunger-driven overconsumption that FTO amplifies, and many carriers respond well. Discuss with a clinician.

**Q: Is FTO the only obesity gene?**
A: No — over 1000 BMI-associated SNPs exist, but FTO has the largest per-allele effect among common variants. Combined polygenic scores capture more risk.

## Citations
- Frayling et al., Science 2007 (PMID 17434869): Original GWAS discovery of FTO rs9939609 and BMI.
- Kilpeläinen et al., PLoS Med 2011 (PMID 22087076): Physical activity attenuates FTO effect on obesity by ~30%.
- Cecil et al., NEJM 2008 (PMID 19073975): FTO risk-allele children consume more energy-dense foods, not larger volumes.

Disclaimer: Informational only — not medical advice.